Canadian Cancer Trials Group

This early-stage study aimed to find the safest dose of a new four-drug combination (romidepsin plus GDP) for patients with two types of aggressive lymphoma that had returned after prior treatment. The main goal was to determine how much of the new drug could be added without cau…

This study compared two different dosing schedules for the drug palbociclib when combined with standard hormone therapy for advanced breast cancer. Researchers wanted to see if a lower daily dose (100 mg every day) would work as well or better than the standard schedule (125 mg f…

This study tested a new oral drug called RP-6306, given alongside standard chemotherapy, for people with advanced cancers that had stopped responding to other treatments. Researchers wanted to see if the drug was safe and if it helped shrink tumors, especially in patients whose c…

This study tested whether a shot called IMM-101 could help prevent severe respiratory and COVID-19 infections in cancer patients. About 195 patients undergoing cancer treatment, who were at higher risk due to age or other health conditions, were randomly assigned to receive the s…